PROVERA‡ + CEE (n=118) Normal/No hyperplasia (%) 116 (97) 45 (38) 112 (95) Simple (cystic) hyperplasia (%) 1 (1) 33 (28) 4 (3) Complex (adenomatous) hyperplasia (%) 1 (1) 27 (22) 2 (2) Atypia (%) 0: 14 (12) 0: Adenocarcinoma (%) 1 (1) 0: 0 *Includes most extreme abnormal result †CEE = conjugated equine estrogens 0.625 mg/day ‡PROVERA = medroxyprogesterone acetate tablets 10 mg/day for 12. Hate having to take birth control pills? The Depo-Provera birth control shot may be a good alternative for you. Learn more about the pros, cons, and effectiveness of the Depo-Provera shot at WebMD. Q: I have no period and did not bleed at all even after taking Provera.What does this mean? A: Provera is given as the 'Progesterone (Provera) Challenge Test' to women who have no period and who are not pregnant.In this test, 10 mg of Provera is often given over 7-10 days and bleeding is expected within 2 weeks after the last pill. Aprenda a tocar a cifra de Deus Proverá (Gabriela Gomes) no Cifra Club. Não vivo pela vista, não / Eu vivo pela fé, então / Deus proverá! Deus proverá! / Olho para o alto, então / Vem o socorro, sim! / Deus proverá! Deus proverá! In 5 Depo-Provera clinical studies, the 3 month failure rate for the group of women treated with Depo-Provera was zero (no pregnancies reported to 0.7 by Life-Table method). 21,22 The effectiveness of Depo-Provera is dependent on the woman returning every 3 months for reinjection. Women with lower bodyweights conceive sooner than women with higher bodyweights after discontinuation of Depo. Provera Side Effects. Generic name: medroxyprogesterone Medically reviewed by Drugs.com. Last updated on Apr 28, 2021. Consumer; Professional; FAQ; Note: This document contains side effect information about medroxyprogesterone. Some of the dosage forms listed on this page may not apply to the brand name Provera. For the Consumer Find patient medical information for Provera oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings. of DEPO-PROVERA Contraceptive Injection in women who were first exposed before the age of 35 years (RR 1.22 to 1.28 and 95% CI 0.93 to 1.70). The overall, nonsignificant relative rate of invasive squamous-cell cervical cancer in women who ever used DEPO-PROVERA Contraceptive Injection was estimated to be 1.11 (95% CI 0.96 to 1.29). No trends. No adverse effects have been noted. However, due to limitations of the data regarding the effects of MPA in breastfed infants less than six weeks old, Provera should be given no sooner than six weeks post-partum when the infant's enzyme system is more developed. Depo-Provera is injected into a muscle or under the skin. A healthcare provider will give you this injection once every 3 months (12 to 14 weeks). You may have breakthrough bleeding while using Depo-Provera. Tell your doctor if this bleeding continues or is very heavy. Depo-Provera can affect the results of certain medical tests. Tell any.